News & Media
Learn more about the latest happenings at Otsuka. Select to see US news or read our press releases. You can also stay up to date with our global news in the link below.
Media Contact:
Senior Director, External Communications,
Otsuka America Pharmaceutical, Inc
Ten innovators from around the world will participate in the first-ever AGE-WELL Pitch Competition: Technology to Support People with Dementia. The competition will showcase a wide range of technology solutions that address the many challenges faced by people living with dementia. Each finalist will deliver a fast-paced, five-minute presentation to a panel of expert judges who will select a
Designation provides the opportunity for more frequent interactions with FDA during clinical development and potential eligibility for priority review Valby, Denmark and Princeton, New Jersey - July 7, 2016 – H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Development & Commercialization, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track
Tokyo, Japan and Redwood City, Calif. – April 26, 2016 – Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for their Digital Medicine, a drug/device combination product, which combines Otsuka’s ABILIFY® (aripiprazole), an atypical antipsychotic,